Senseonics updates corporate presentation at Stifel Healthcare Conference

Senseonics Holdings, Inc.

Presentation highlights Eversense 365 CGM system FDA clearance and commercial launch.
Collaboration with Mercy Health targeting up to 30,000 patients initiated Q3 2024, expansion expected 2025.
Gemini (self-powered) and Freedom (no transmitter) development programs progressing with IDE filing planned 2025.
CGM market opportunity described as $20B+ US TAM with ~21% CAGR.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.